 Home > Active Ingredient News > Immunology News > "The King of Medicine" HUMIRA (Adalimumab) gets a new indication: FDA approved for the treatment of ulcerative colitis in children

"The King of Medicine" HUMIRA (Adalimumab) gets a new indication: FDA approved for the treatment of ulcerative colitis in children

 Last Update: 2021-03-21
 Source: Internet
 Author: User

Tags

ultrasound weight loss

96 blood sugar

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

medsci.

Manage FDA children

Brandee Pappalardo, Vice President of American Immunology Affairs of AbbVie, said: "Ulcerative colitis may have a profound impact on children, and treatment options for pediatric patients are limited.

immunity

The approval is based on the pivotal ENVISION I study, which showed that HUMIRA reached its primary endpoint of clinical remission at week 8.

For patients who achieve remission in the 8th week, clinical remission can last for one year (52 weeks).

Original source:

https://target="_blank" rel="noopener">https:// style="vertical-align: inherit;"> https:// leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

High quality Thymosin α1 Pure CAS 62304-98-7 Thymosin Alpha 1 Thymalfasin

CAS No.: 62304-98-7

Pharmacy Grade

$12-15/UNIT FOB

Top quantity Imiquimod CAS NO 99011-02-6 White crystalline powder 99% API

CAS No.: 99011-02-6

Pharmacy Grade

$1800-1850/KG FOB

Upadacitinib

CAS No.: 1310726-60-3

Pharma Grade

$60750/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.